|
3.2 WASTE DESCRIPTION
<br />Diesel Fuel
<br />The hazardous constituent of diesel fuel is benzene. Benzene comprises approximately 0.002 to
<br />0.011% of the total fuel mixture. Dermal contact with diesel fuel can cause minor eye irritation and
<br />dermal rash. Prolonged breathing of vapors can impact on the central nervous system. Diesel fuel is
<br />not generally expected to have acute systemic toxicity by ingestion. Ingestion of diesel fuel and/or
<br />subsequent vomiting can result in aspiration of light hydrocarbon liquid which can cause pneumonitis.
<br />There is no Federal or State OSHA PEL or ACGIH TLV standard established for diesel fuel.
<br />Gasoline
<br />Gasoline can pose a significant health hazard. The organic lead compounds, tetraethyllead (TEL) and
<br />tetramethyllead {TML) are constituents of gasoline as antiknock compounds. Health problems
<br />associated with lead are headache, anxiety, insomnia, nervous excitation and minor gastrointestinal
<br />symptoms with a metallic taste in the mouth. Liquid alkyllead may penetrate the skin without producing
<br />appreciable local injury. However, the decomposition products (i.e., mono-, di-, and triethyllead
<br />compounds) in dust form may be inhaled and result in irritation of the upper respiratory tract and
<br />possibly paroxysmal sneezing. This dust, when in contact with moist skin or ocular membranes, may
<br />cause itching, burning, and transient redness. TEL itself is irritating to the eyes. The absorption of a
<br />sufficient quantity of TEL whether briefly at a high rate, or for prolonged periods at a lower rate, may
<br />give rise to a variety of symptoms which include mild anxiety, toxic delirium with hallucinations,
<br />delusions, convulsions, and acute toxic psychosis. Physical signs are not prominent; but bradychardia,
<br />hypotension, increased reflexes, tremor, and slight weight loss have been reported. When the interval
<br />between the termination of exposure and the onset of symptoms is short, an early fatal outcome may
<br />result. Exposure to TML may produce insomnia, bad dreams, restlessness, anxiousness, hypotension,
<br />nausea, aneroxia, delirium, mania, convulsions, coma. The points of attack for both TEL and TML are
<br />the central nervous system, cardiovascular system, kidneys and eyes. The acceptable method for
<br />monitoring lead contamination in humans is hair or blood analysis. The permissible level of lead in
<br />PEUTLV
<br />STEL
<br />IDHL
<br />Lead
<br />0.1 mg/m3
<br />Tetraethyllead
<br />0.075 mg/m3
<br />0.3 mg/m3
<br />40 mg/m3
<br />Tetramethyllead
<br />0.07 mg/m3
<br />0.5 mg/m3
<br />40 mg1m3
<br />Benzene
<br />10 ppm
<br />25 ppm
<br />2,000 ppm
<br />Toluene
<br />100 ppm
<br />150 ppm
<br />2,000 ppm
<br />Ethylbenzene
<br />100 ppm
<br />125 ppm
<br />2,000 ppm
<br />Xylene
<br />100 ppm
<br />150 ppm
<br />10,000 ppm
<br />Gasoline
<br />Gasoline can pose a significant health hazard. The organic lead compounds, tetraethyllead (TEL) and
<br />tetramethyllead {TML) are constituents of gasoline as antiknock compounds. Health problems
<br />associated with lead are headache, anxiety, insomnia, nervous excitation and minor gastrointestinal
<br />symptoms with a metallic taste in the mouth. Liquid alkyllead may penetrate the skin without producing
<br />appreciable local injury. However, the decomposition products (i.e., mono-, di-, and triethyllead
<br />compounds) in dust form may be inhaled and result in irritation of the upper respiratory tract and
<br />possibly paroxysmal sneezing. This dust, when in contact with moist skin or ocular membranes, may
<br />cause itching, burning, and transient redness. TEL itself is irritating to the eyes. The absorption of a
<br />sufficient quantity of TEL whether briefly at a high rate, or for prolonged periods at a lower rate, may
<br />give rise to a variety of symptoms which include mild anxiety, toxic delirium with hallucinations,
<br />delusions, convulsions, and acute toxic psychosis. Physical signs are not prominent; but bradychardia,
<br />hypotension, increased reflexes, tremor, and slight weight loss have been reported. When the interval
<br />between the termination of exposure and the onset of symptoms is short, an early fatal outcome may
<br />result. Exposure to TML may produce insomnia, bad dreams, restlessness, anxiousness, hypotension,
<br />nausea, aneroxia, delirium, mania, convulsions, coma. The points of attack for both TEL and TML are
<br />the central nervous system, cardiovascular system, kidneys and eyes. The acceptable method for
<br />monitoring lead contamination in humans is hair or blood analysis. The permissible level of lead in
<br />
|